drugset / Trial / NCT01269606

Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

NCT01269606

Phase 1 Completed 13 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Japan. The aim of the trial is to compare pharmacokinetics (at which rate the body eliminates the substance from the body) of insulin aspart with fast-acting insulin human following intravenous (IV) infusion or intramuscular (IM) injection in Japanese subjects with type 1 diabetes mellitus.

Timeline

Start
2011-01
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 0.2 iu/kg Intramuscular
Subject insulin aspart Protein / enzyme biologic 0.2 iu/kg Intramuscular